Skip to main content


Fig. 4 | BMC Endocrine Disorders

Fig. 4

From: Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease

Fig. 4

Changes in the TG and LDL concentrations in the three groups at the 0th, 16th, and 32nd weeks. The TG (a) and LDL (b) levels were higher in the two HFD groups at the 16th week, but the differences between the groups were not significant. Over the next 16 weeks, BBR reversed the elevated TG and LDL levels to levels similar to the NCD group. The data are expressed as the means ± SEM. &P < 0.05, NCD vs NAFLD; #P < 0.05, NAFLD vs NAFLD + BBR

Back to article page